Humacyte, Inc. Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 9,476.35%2,772.77%1,902.29%1,533.25%1,288.92%
EBIT Margin 9,202.28%2,632.35%1,825.24%1,516.09%1,233.16%
EBITDA Margin 9,476.35%858.25%258.14%1,678.68%1,602.90%
Operating Margin 9,202.28%2,632.35%1,825.24%1,516.09%1,233.16%
Net Margin 9,476.35%2,772.77%1,902.29%1,533.25%1,288.92%
FCF Margin 7,965.53%2,639.22%1,557.22%1,145.40%1,074.64%
Leverage & Solvency
Interest Coverage Ratio -29.34-18.68-13.65-15.16-12.33
Times Interest Earned -29.34-18.68-13.65-15.16-12.33
Valuation
Enterprise Value 134.46M746.77M217.58M294.15M635.59M
Market Capitalization 134.46M746.77M217.58M294.15M635.59M
Return Ratios
Return on Sales 94.76%27.73%19.02%15.33%12.89%